Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
developing theory, innovative modeling tools for large-scale biophysical simulations, and computational frameworks for analyzing increasingly large and complex experimental datasets. Living systems are built
-
well as developing new targeted therapies for hematological malignant diseases and cancers. Our research involves experiments with various biochemistry and molecular techniques, genomic approaches, and genetic and
-
, , Annals of Surgery, etc. If you are interested, please send your CV directly to Dr. Goel at ajgoel@coh.org. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays
-
developing drugs for the treatment of cancer, vascular anomalies, macular degeneration and glaucoma. The group is dedicated to identifying novel targets, pursuing high throughput screening of therapeutics and
-
, clinical computational oncology), and health policy (BIDMC’s Health Policy Section at the Smith Center for Outcomes Research), providing an exceptional environment for postdoctoral fellows to develop and
-
or experimental medicine, offering up to 36 months of funding to develop an externally funded intermediate clinician scientist research proposal, including preliminary data generation. The Chain Florey
-
the laboratory of Dr. Qiang Zhu (https://zhulab.vai.org/) at Van Andel Institute (VAI). The research group combines multidisciplinary technologies to study disease mechanisms and develop innovative therapeutic
-
The Postdoctoral Fellow for the Department of Biochemistry and Molecular Biology will be responsible for contributing to the development and application of advanced proteomic technologies
-
, from studies of the behaviour of single molecules, to developing cells, neuronal circuits, and up to entire ecosystems full of living things. We are supported by platform technologies and facilities
-
tissue from the large brain bank at JHU to develop an integrated understanding of the disease. The ultimate goal of the BSL is to understand the biology of these diseases, to define novel biomarkers, and